Paclitaxel-coated balloon study: quantitative coronary angiography and optical coherence tomography evaluation in a swine in-stent stenosis model




Background


Drug-coated balloons (DCBs) have shown efficacy for treatment of coronary artery disease. In the PEPCAD II ISR trial, paclitaxel-coated balloon (PCB) reduced in-stent restenosis (ISR) compared with paclitaxel-eluting stent (PES). Here we evaluated the efficacy of PCB in a porcine ISR model.




Materials and methods


Thirty-two coronary arteries (LAD: n =12, LCX: n =11, RCA: n =9) of 24 Yorkshire pigs were assigned to two groups randomly. PCB (SeQuent, length 20 mm, n =16) or noncoated balloon (NCB, length 20 mm, n =16) was inflated for 60 s with B:A 1.2:1 followed by BMS (length 12 mm) implantation (S/A 1.5:1) within the target region. At 28 days, animals underwent restudy for the assessment of quantitative coronary angiography (QCA) and optical coherence tomography (OCT).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Paclitaxel-coated balloon study: quantitative coronary angiography and optical coherence tomography evaluation in a swine in-stent stenosis model

Full access? Get Clinical Tree

Get Clinical Tree app for offline access